Invesco Ltd. Kal Vista Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 15,640 shares of KALV stock, worth $156,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,640

Previous 14,557 7.44%

Holding current value

$156,869

Previous $168,000 21.43%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$8.09 - $12.5 $8,761 - $13,537	1,083 Added 7.44%	15,640 $132,000
Q3 2024 Nov 12, 2024	BUY	$9.46 - $15.39 $2,620 - $4,263	277 Added 1.94%	14,557 $168,000
Q2 2024 Aug 13, 2024	BUY	$10.35 - $12.49 $3,187 - $3,846	308 Added 2.2%	14,280 $168,000
Q1 2024 May 14, 2024	BUY	$11.07 - $16.04 $5,479 - $7,939	495 Added 3.67%	13,972 $165,000
Q4 2023 Feb 12, 2024	BUY	$7.58 - $12.25 $102,155 - $165,093	13,477 New	13,477 $165,000
Q1 2023 May 12, 2023	SELL	$6.3 - $8.39 $6,747 - $8,985	-1,071 Reduced 9.55%	10,147 $79,000
Q4 2022 Feb 13, 2023	BUY	$4.2 - $14.24 $47,115 - $159,744	11,218 New	11,218 $75,000
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $126,343 - $186,858	-10,222 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $2.49 Million - $3.57 Million	-145,618 Reduced 93.44%	10,222 $178,000
Q2 2021 Aug 17, 2021	BUY	$23.12 - $29.91 $3.6 Million - $4.66 Million	155,840 New	155,840 $3.73 Million
Q2 2020 Aug 14, 2020	SELL	$6.75 - $12.89 $73,467 - $140,294	-10,884 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.8 - $18.56 $63,127 - $202,007	10,884 New	10,884 $83,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $116,059 - $200,487	-11,257 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$11.6 - $21.67 $2.87 Million - $5.36 Million	-247,416 Reduced 95.65%	11,257 $130,000
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $1.02 Million - $1.7 Million	-55,118 Reduced 17.57%	258,673 $5.73 Million
Q1 2019 May 15, 2019	BUY	$16.51 - $31.1 $615,294 - $1.16 Million	37,268 Added 13.48%	313,791 $8.98 Million
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $4.48 Million - $6.65 Million	276,523 New	276,523 $5.46 Million

Others Institutions Holding KALV

# of Institutions

131

Shares Held

53.3M

Call Options Held

63.5K

Put Options Held

36.6K

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $247M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account